Sugammadex in a Patient with Brugada Syndrome
PDF
Cite
Share
Request
Case Report
P: 99-101
April 2016

Sugammadex in a Patient with Brugada Syndrome

Turk J Anaesthesiol Reanim 2016;44(2):99-101
1. Çukurova Üniversitesi Tıp Fakültesi, Anesteziyoloji ve Reanimasyon Anabilim Dalı, Adana, Türkiye
No information available.
No information available
Received Date: 05.01.2015
Accepted Date: 14.05.2015
PDF
Cite
Share
Request

ABSTRACT

Brugada Syndrome was first described in1992 by Pedro Brugada as a genetic syndrome that is characterized by ventricular arrhythmias that may result in sudden cardiac arrest. In particular, a right bundle branch block and ST segment elevation in the right precordial leads are observed. Many perioperative pharmalogical and physiological factors can trigger malignant arrhythmias. Although it is a rare condition, the anaesthestic management of Brugada syndrome is important because of the potentially fatal complications. Many anaesthetics have been administered during the operation of patients with Brugada Syndrome. The use of sugammadex instead of the anaesthetic management of patients with Brugada syndrome is discussed in this study.

Keywords:
Brugada Syndrome, sugammadex, anaesthesia